FL
LGND icon

Fort LP’s Ligand Pharmaceuticals LGND Stock Holding History

Fort LP’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-463
Closed -$36K – 459
2019
Q1 		$36K Sell
463
-234
-34% -$17.7K 0.01% 381
2018
Q4 		$59K Hold
697
– – 0.01% 343
2018
Q3 		$119K Buy
+697
New +$105K 0.03% 275

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fort LP's LGND Position: Q2 2019 in Review

Fort LP sold out of Ligand Pharmaceuticals (LGND) in Q2 2019, closing a stake of 463 shares — an estimated $36K sold.

Fort LP first reported a position in LGND in Q3 2018 and held it in 3 quarters. The position peaked at $119K in Q3 2018. 305 funds tracked by Wall St. Rank hold LGND as of Q2 2019.

  • Fort LP reported no remaining Ligand Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Fort LP sold 463 Ligand Pharmaceuticals shares in Q2 2019, an estimated $36K.
  • Fort LP first reported a position in Ligand Pharmaceuticals in Q3 2018 and held it in 3 quarters.
  • Fort LP's Ligand Pharmaceuticals position peaked at $119K in Q3 2018.
  • 305 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2019.

Based on Fort LP's 13F filing for Q2 2019, filed 13 Aug 2019.